000			01497 a2200445 4500
005			20250513213352.0
264		0	_c20000720
008			200007s 0 0 eng d
022			_a0013-7227
024	7		_a10.1210/endo.141.7.7535 _2doi
040			_aNLM _beng _cNLM
100	1		_aCipriano, S C
245	0	0	_aFollistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice. _h[electronic resource]
260			_bEndocrinology _cJul 2000
300			_a2319-27 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aActivins
650	0	4	_aAnimals
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aFollistatin
650	0	4	_aGlycoproteins _xgenetics
650	0	4	_aInhibins _xblood
650	0	4	_aLiver Diseases _xgenetics
650	0	4	_aMale
650	0	4	_aMetallothionein _xgenetics
650	0	4	_aMice
650	0	4	_aMice, Transgenic _xgenetics
650	0	4	_aOvarian Neoplasms _xgenetics
650	0	4	_aPeptides _xgenetics
650	0	4	_aStomach Diseases _xgenetics
650	0	4	_aSurvival Analysis
650	0	4	_aTesticular Neoplasms _xgenetics
650	0	4	_aWasting Syndrome _xetiology
700	1		_aChen, L
700	1		_aKumar, T R
700	1		_aMatzuk, M M
773	0		_tEndocrinology _gvol. 141 _gno. 7 _gp. 2319-27
856	4	0	_uhttps://doi.org/10.1210/endo.141.7.7535 _zAvailable from publisher's website
999			_c10825912 _d10825912